Pharma chemical from China and Saudi Arabia faces anti-dumping duty

In the probe, DGTR will determine the existence, degree and effect of any alleged dumping.

The government may impose anti-dumping duty on a chemical used in pharma and pesticide industries from China and Saudi Arabia with a view to guard domestic players from cheap imports.

The commerce ministry's investigation arm Directorate General of Trade Remedies (DGTR) has initiated a probe into an alleged dumping of Dimethyl Formamide from these two countries following a complaint filed by Balaji Amines Ltd on behalf of domestic industry.

The company has filed an application before the directorate for investigation into the imports from these countries for imposing anti-dumping duty.

DGTR in a notification said on the basis of the prima facie evidence submitted by the company about dumping of the product by firms in these two nations, " the authority, hereby, initiates an investigation".

In the probe, DGTR will determine the existence, degree and effect of any alleged dumping.

If it will be established that the dumping has impacted the domestic industry, the directorate would recommend imposition of the duty. The finance ministry will take the final decision to impose the duty.

The period of investigation is January to September 2019 (9 months). It would also look at the data of 2016-19.

Countries carry out anti-dumping probe to determine whether their domestic industries have been hurt because of a surge in cheap imports. As a counter measure, they impose duties under the multilateral regime of the World Trade Organisation.

The duty is aimed at ensuring fair trade practices and creating a level-playing field for domestic producers with regard to foreign producers and exporters.


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel